Home World Kaipu Bio: The company has no new crown oral drugs, injection drugs, special drug R&D, sales, and agency processes_ Oriental Fortune Network

Kaipu Bio: The company has no new crown oral drugs, injection drugs, special drug R&D, sales, and agency processes_ Oriental Fortune Network

by admin


Every time we pass the AI ​​Express, some investors ask questions on the investor interactive platform: Does the company have drug research and development or export business? Are there new development, sales, and agency processes for new crown oral drugs, injection drugs, and special drugs?

  Cap Bio(300639.SZ) said on the investor interaction platform on January 14 that the company currently has no new crown oral drugs, injection drugs, and special drug research and development, sales, and agency processes. For the business related to the new crown, the company mainly has new crown nucleic acid detection products and supporting sampling, extraction reagents and nucleic acid extraction equipment, and relies on its 29 medical laboratories to carry out the new crown nucleic acid detection business. The company is a leading provider of nucleic acid molecular diagnostic products and services in China. It has developed a series of nucleic acid detection products in the fields of maternal and child health, birth defects and infectious diseases, which are widely used in hospital clinical diagnosis, large-scale population screening, public health prevention and control, etc. In recent years, it has further extended to the downstream of the industrial chain, focusing on expanding third-party medical testing services, and building an integrated business model of “nucleic acid testing products + medical testing services”. In the field of pharmaceuticals, the company has developed the drug “Chloroquine Phosphate Gel” and is currently conducting Phase II clinical trials for efficacy and safety evaluation.Please pay attention to the specific situation of the companyCompany Announcement

(Article source: Daily Economic News)


Article source: Daily Economic News

Responsible editor: 20

Original title: Kaipu Bio: The company has no new crown oral drugs, injection drugs, and special drug research and development, sales, and agency processes

Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.

report

Share to WeChat Moments

Open WeChat,

Click “Discover” at the bottom

Use “Sweep”

You can share the webpage to the circle of friends

Scan the QR code to follow

Oriental Fortune official website WeChat

.

0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy